Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 182 700 KRW -1.08% Market Closed
Market Cap: 2.1T KRW

Daewoong Pharma
Pre-Tax Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Daewoong Pharma
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Daewoong Pharma
KRX:069620
Pre-Tax Income
â‚©85.7B
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
5%
Yuhan Corp
KRX:000100
Pre-Tax Income
â‚©73.9B
CAGR 3-Years
-17%
CAGR 5-Years
-20%
CAGR 10-Years
-5%
SK Biopharmaceuticals Co Ltd
KRX:326030
Pre-Tax Income
â‚©96.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Pre-Tax Income
â‚©145B
CAGR 3-Years
4%
CAGR 5-Years
20%
CAGR 10-Years
17%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Pre-Tax Income
â‚©3.7B
CAGR 3-Years
N/A
CAGR 5-Years
-25%
CAGR 10-Years
-15%
C
Caregen Co Ltd
KOSDAQ:214370
Pre-Tax Income
â‚©35.9B
CAGR 3-Years
2%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
No Stocks Found

Daewoong Pharma
Glance View

Market Cap
2.1T KRW
Industry
Pharmaceuticals

Daewoong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2002-11-01. The firm's products mainly include antihypertensive drugs, antianemic agents, antidiabetic agents, antiemetic agents, antihistamine agents, antimicrobials, antineoplastics, antiobesity agents, antipyretic agents, analgesic agents, anti-inflammatory agents, biosimilars, remedies for bone and joint diseases, cardiovascular treatments, central nervous system treatments, digestive agents, dermatologic agents, gastrointestinal agents, health supplements and respiratory remedies, among others. The firm distributes its products in domestic and overseas markets.

Intrinsic Value
265 671.67 KRW
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Daewoong Pharma's Pre-Tax Income?
Pre-Tax Income
85.7B KRW

Based on the financial report for Jun 30, 2025, Daewoong Pharma's Pre-Tax Income amounts to 85.7B KRW.

What is Daewoong Pharma's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
5%

Over the last year, the Pre-Tax Income growth was -18%. The average annual Pre-Tax Income growth rates for Daewoong Pharma have been 3% over the past three years , and 5% over the past ten years .

Back to Top